SureTrader
Home > Boards > US Listed > Medical - Healthcare >

Precision Therapeutics Inc. (AIPT)

AIPT RSS Feed
Add AIPT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/9/2018 9:01:41 PM - Followers: 105 - Board type: Free - Posts Today: 0

 


Jan 25, 2018

Skyline Medical Announces Corporate Name Change to Precision Therapeutics

http://investors.skylinemedical.com/news-releases/news-release-details/skyline-medical-announces-corporate-name-change-precision
 

The STREAMWAY System 

http://www.skylinemedical.com/wp-content/uploads/Skyline-Medical-Streamway-System.pdf 

 

Skyline Medical Inc. Enters into Strategic Collaboration with Helomics to Develop Next Generation of Personalized Cancer Diagnostics

Skyline Medical Inc. (NASDAQ: SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, and Helomics Corporation (Pittsburgh, PA)  have announced a strategic collaboration to use the Helomics D-CHIP™ platform to develop new approaches for personalized cancer diagnosis and care.
https://www.helomics.com/single-post/2017/11/02/Skyline-Medical-Inc-Enters-into-Strategic-Collaboration-with-Helomics-to-Develop-Next-Generation-of-Personalized-Cancer-Diagnostics

Skyline Medical and Helomics expand into Next Generation Sequencing for Personalized Medicine

"The MiSeqDx NGS platform will allow gene sequencing of tumor specimens from cancer patients which will provide rich genomic data for the D-CHIP™ AI-based bioinformatics platform being built out as part of the Skyline-Helomics joint venture. The D-CHIP platform then identifies the correlations between the patient demographic data, the tumor gene sequence (obtained by NGS), and the drug responses of the individual patient’s tumor. Pharma partners who subscribe to the D-CHIP service can mine the knowledgebase of tumor mutations and drug response to design the next generation of cancer treatments.

“Licensing the NGS platform is expected to drive commercial traction for both the D-CHIP platform and the additional CRO services offered by the Skyline-Helomics joint venture. We fully expect the NGS platform to drive revenue from new partnerships early in 2018,” stated Dr. Carl Schwartz, CEO of Skyline Medical." 

https://www.helomics.com/single-post/2017/12/20/Skyline-Medical-and-Helomics-expand-into-Next-Generation-Sequencing-for-Personalized-Medicine-1
 

Helomics® Corporation Announces the appointment of Dr. Marc Malandro to its Advisory Board, providing strategic insights for the Skyline Medical – Helomics Joint Venture.

https://www.helomics.com/single-post/2018/01/08/Helomics®-Corporation-Announces-the-appointment-of-Dr-Marc-Malandro-to-its-Advisory-Board-providing-strategic-insights-for-the-Skyline-Medical-–-Helomics-Joint-Venture

 

Chan-Zuckerberg: Social Media Monarchy Breeds Philanthropy

A recent BioBreakfast event welcomed Marc Malandro, VP of operations for science at the Chan Zuckerberg Initiative (CZI), back to the city of Pittsburgh. Malandro previously served as Vice Chancellor for Technology Management and Commercialization, as well as Founding Director of the Innovation Institute, at the University of Pittsburgh. Under his leadership, the university filed over 1,100 new U.S. patent applications, was granted 609 U.S. issued patents, entered into over 1,203 license agreements, and formed 86 companies based on university research. Malandro’s productive tenure at Pitt began in 2004 and lasted until his departure for CZI earlier this year.

In his new role, Malandro is part of the CZI team supporting novel advances in the scientific research behind modern medicine. To accelerate this progress, CZI will bring scientists and engineers together in new ways, create computational and experimental tools to empower the scientific community, and build a movement to support basic scientific research. But, where did CZI come from?

https://www.meddeviceonline.com/doc/chan-zuckerberg-social-media-monarchy-breeds-philanthropy-0001

CZI is inseparably linked to the modest beginnings of social media monster Facebook. In January of 2004, then Harvard student Mark Zuckerberg began writing code for a new web site in his dorm room. On Feb. 4, 2004, Zuckerberg launched "Thefacebook," originally located at thefacebook.com. This became the Facebook so many people know and love; it currently is valued at about $500 billion, and Zuckerberg owns about 20 percent of the shares outstanding.

https://www.meddeviceonline.com/doc/chan-zuckerberg-social-media-monarchy-breeds-philanthropy-0001

 
 
SureTrader
AIPT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
AIPT News: Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary 04/09/2018 08:30:00 AM
AIPT News: CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call 04/04/2018 07:00:00 PM
AIPT News: Current Report Filing (8-k) 04/04/2018 04:27:53 PM
AIPT News: Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE... 04/04/2018 12:16:38 PM
AIPT News: Precision Therapeutics Releases Highlights from FY 2017 Business Update Call 04/04/2018 08:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3928   This is a very long running P and Full Contact Yoga 04/09/18 09:01:41 PM
#3927   Sooo many sheeple on ST that are trapped BuynowCryLater 04/09/18 08:42:45 PM
#3926   More fluff nonsense to print that paper...the raping Full Contact Yoga 04/09/18 09:19:05 AM
#3925   The RS is built into the biz plan, Full Contact Yoga 04/06/18 12:50:17 PM
#3924   Wash , rinse , repeat and then Beg BuynowCryLater 04/05/18 05:01:32 PM
#3923   Whole lot of dumping. Likely paint the Full Contact Yoga 04/05/18 03:41:29 PM
#3922   Bob is a dumbass, he's referring to short Full Contact Yoga 04/05/18 09:44:09 AM
#3921   CORRECTING and REPLACING - Precision Therapeutics Releases Highlights geodan 04/04/18 07:03:43 PM
#3920   Short 42% from CFO in CC geodan 04/04/18 06:59:11 PM
#3919   Got some wild numbers floating around here with MaineMan5 04/04/18 03:58:14 PM
#3918   Short interest only 2.4%, short volume irrelevant, unrelated Full Contact Yoga 04/04/18 02:46:34 PM
#3917   Short Position is 42% according to them in geodan 04/04/18 02:19:28 PM
#3916   Bought it on the .85 cent break, grateful Full Contact Yoga 04/04/18 02:14:14 PM
#3915   Well you are in zero position to know geodan 04/04/18 01:52:13 PM
#3914   You are pumping a turd. Ask for a Full Contact Yoga 04/04/18 01:47:30 PM
#3913   His background is irrelevant, look at the 17 Full Contact Yoga 04/04/18 01:47:02 PM
#3912   What is your position now and history on geodan 04/04/18 01:47:01 PM
#3911   He's a longtime holder of the longtime P Full Contact Yoga 04/04/18 01:35:00 PM
#3910   Yoga, Carl's background does not match up with geodan 04/04/18 01:26:50 PM
#3909   Are you saying he has been there a geodan 04/04/18 01:22:14 PM
#3908   How found it is Lsigard https://reminiscencesofastockblogger.com/ geodan 04/04/18 01:17:13 PM
#3907   Yes, invalidated, forward looking, typical Carl and Bob Full Contact Yoga 04/04/18 01:16:40 PM
#3906   Yoga, extreme gyrations on stock. Is Carl geodan 04/04/18 01:15:48 PM
#3905   Here is the video:https://www.youtube.com/watch?time_continue=6&v=zeyZY4c0sw4 of geodan 04/04/18 01:12:32 PM
#3904   Going ..;) stock1ace1 04/04/18 01:12:25 PM
#3903   Low floater with news, could get some legs. UP Trend 04/04/18 12:47:16 PM
#3902   Precision Therapeutics is the First Company to Grow Paullee 04/04/18 12:27:21 PM
#3901   Same old fluff, 52 week low well deserved, Full Contact Yoga 04/04/18 10:56:03 AM
#3900   Precision Therapeutics Releases Highlights from FY 2017 Business Paullee 04/04/18 09:06:17 AM
#3899   This is true ???? wash rinse repeat BuynowCryLater 04/03/18 11:05:40 AM
#3898   The RS will go off as planned, every Full Contact Yoga 04/03/18 10:41:17 AM
#3897   Thanks Paullee,just read SAarticle,wow +CC link geodan 04/02/18 05:59:49 PM
#3896   CC Notes: $3.5million+Projection2018,55% Consumables StreamWay geodan 04/02/18 05:41:04 PM
#3895   Conference Call and Webcast into strats in 2 mins geodan 04/02/18 04:30:27 PM
#3894   Huge good news today, 16 sales 1Q, geodan 03/29/18 10:44:35 PM
#3893   Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement wit Paullee 03/21/18 12:16:45 PM
#3892   Not too far off. Will go under Full Contact Yoga 03/20/18 03:23:21 PM
#3891   When is the next annual RS ? BuynowCryLater 03/19/18 04:23:00 PM
#3890   MGTI should do well tomorrow with Bitcoin down michaeland1 03/19/18 12:54:21 AM
#3889   Not until 4/2, should test $1 before then, Full Contact Yoga 03/15/18 11:14:57 PM
#3888   Possible ER tomorrow AH Full Contact Yoga 03/14/18 04:03:15 PM
#3887   Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement wit Paullee 03/13/18 10:10:21 AM
#3886   $AIPT hmmm lots of chat rooms discussing this SkipDawg 03/11/18 09:18:01 PM
#3885   $AIPT GONNA RUN LIKE A RAPPED APE ONCE SkipDawg 03/10/18 10:09:35 PM
#3884   MGTI: -9% michaeland1 03/09/18 05:52:52 PM
#3881   as entertaining as you two dipshits are, it's Churak 03/09/18 05:28:24 AM
#3873   You can trick new traders/investors with a name BuynowCryLater 03/08/18 10:36:07 AM
#3872   I wouldn't delete anything you queefed, it was Full Contact Yoga 03/07/18 08:48:23 AM
#3871   Did you delete my message? Weird that michaeland1 03/07/18 01:06:36 AM
#3868   Clearly you have no idea what you are Full Contact Yoga 03/02/18 05:16:11 PM
PostSubject